Nadežda Basara

3.7k total citations
70 papers, 2.1k citations indexed

About

Nadežda Basara is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Nadežda Basara has authored 70 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Hematology, 30 papers in Oncology and 15 papers in Genetics. Recurrent topics in Nadežda Basara's work include Hematopoietic Stem Cell Transplantation (24 papers), Acute Myeloid Leukemia Research (13 papers) and Polyomavirus and related diseases (10 papers). Nadežda Basara is often cited by papers focused on Hematopoietic Stem Cell Transplantation (24 papers), Acute Myeloid Leukemia Research (13 papers) and Polyomavirus and related diseases (10 papers). Nadežda Basara collaborates with scholars based in Germany, United States and Argentina. Nadežda Basara's co-authors include Olle Ringdén, Dietger Niederwieser, Dietrich W. Beelen, A. A. Fauser, AA Fauser, Rainer Schwerdtfeger, Mats Remberger, Gerhard Ehninger, M. Bischoff and D Kirsten and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Nadežda Basara

69 papers receiving 2.0k citations

Peers

Countries citing papers authored by Nadežda Basara

Since Specialization

Citations

This map shows the geographic impact of Nadežda Basara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadežda Basara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadežda Basara more than expected).

Fields of papers citing papers by Nadežda Basara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadežda Basara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadežda Basara. The network helps show where Nadežda Basara may publish in the future.

Co-authorship network of co-authors of Nadežda Basara

This figure shows the co-authorship network connecting the top 25 collaborators of Nadežda Basara. A scholar is included among the top collaborators of Nadežda Basara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadežda Basara. Nadežda Basara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	AFM13 in Patients with Relapsed or Refractory Hodgkin Lymphoma: Final Results of an Open-Label, Randomized, Multicenter Phase II Trial 2020 ·Blood ·Stephanie Sasse, (unknown), Annette Plütschow, Andreas Hüttmann, Nadežda Basara, Christian Koenecke, Sonja Martin, Martin Bentz, Christina Große-Thie, (unknown), Maike de Wit, Carsten Kobe, Markus Dietlein, Bastian von Tresckow, Michael Fuchs, Peter Borchmann, Andreas Engert	8
2	Long-term survival of sorafenib-treated FLT3-ITD–positive acute myeloid leukaemia patients relapsing after allogeneic stem cell transplantation 2017 ·European Journal of Cancer ·Stephan Metzelder, Thomas Schroeder, Michael Lübbert, Markus Ditschkowski, Katharina S. Götze, Sebastian Scholl, Ralf G. Meyer, Peter Dreger, Nadežda Basara, Martin F. Fey, Helmut R. Salih, (unknown), Thomas Pabst, Aristoteles Giagounidis, Guido Kobbe, Ellen Wollmer, Jürgen Finke, Andreas Neubauer, Andreas Burchert	59
3	Diagnosis and Treatment of Ocular Chronic Graft-Versus-Host Disease: Report From the German–Austrian–Swiss Consensus Conference on Clinical Practice in Chronic GVHD 2011 ·Cornea ·Tina Dietrich-Ntoukas, Claus Cursiefen, Henrike Westekemper, Philipp Eberwein, Thomas Reinhard, Hartmut Bertz, Johannes Nepp, Ánita Lawitschka, Arnd Heiligenhaus, Berthold Seitz, Elisabeth M. Messmer, Tobias Meyer‐ter‐Vehn, Nadežda Basara, Hildegard Greinix, Manuel B. Datiles, Stephanie J. Lee, Steven Z. Pavletic, Daniel Wolff	110
4	Early related or unrelated haematopoietic cell transplantation results in higher overall survival and leukaemia-free survival compared with conventional chemotherapy in high-risk acute myeloid leukaemia patients in first complete remission 2009 ·Leukemia ·Nadežda Basara, Antina Schulze, Ulrich Wedding, Martin Mohren, Axel Gerhardt, Christian Junghanß, N. Peter, Gottfried Dölken, Cornelia Becker, Simone Heyn, (unknown), Thoralf Lange, Rainer Krahl, Wolfram Pönisch, H.-J. Fricke, Herbert G. Sayer, Haifa Kathrin Al‐Ali, F Kamprad, Dietger Niederwieser, (unknown)	63
5	Reduced-intensity conditioning regimen using low-dose total body irradiation before allogeneic transplant for hematologic malignancies: Experience from the European Group for Blood and Marrow Transplantation 2006 ·International Journal of Radiation OncologyBiologyPhysics ·Yazid Belkacémi, Myriam Labopin, Christophe Hennequin, S. Hoffstetter, (unknown), Marc Wygoda, Marie Lundell, Jürgen Finke, (unknown), (unknown), C. Durdux, Nadežda Basara	9
6	Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complications 2004 ·Bone Marrow Transplantation ·Dietrich W. Beelen, Rudolf Trenschel, J. Casper, Mathias Freund, Ralf A. Hilger, M. E. Scheulen, Nadežda Basara, A. A. Fauser, Bernd Hertenstein, (unknown), Joachim Baumgart, Uwe Pichlmeier, J. Hahn, Ernst Holler	84
7	Gene Therapy for Sarcoma 2002 ·Cells Tissues Organs ·Stefan Früehauf, Marlon R. Veldwijk, (unknown), Nadežda Basara, Christel Baum, Michael Flaßhove, Susanna Hegewisch‐Becker, Nicolaus Kröger, Thomas Licht, Tassilo Moritz, Ulrich R. Hengge, W. Jens Zeller, Stephanie Laufs	10
8	Biological and Clinical Significance of Clonogenic Assays in Patients with Myelodysplastic Syndromes 2002 ·Medical Oncology ·Dragomir Marisavljević, Z Rolović, (unknown), Nadežda Basara, Duško Ilić, D Bošković, (unknown)	12
9	Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience 2001 ·Transplantation Proceedings ·Nadežda Basara, M. G. Kiehl, (unknown), Eric J. Romer, M. Bischoff, (unknown), D Kirsten, S Günzelmann, A. A. Fauser	38
10	New immunosuppressants in BMT/GVHD 2001 ·Transplantation Proceedings ·Nadežda Basara, S Günzelmann, Wolfgang Willenbacher, A. A. Fauser, M. G. Kiehl	8
11	A comparative study of peripheral blood stem cell vs bone marrow transplantation from unrelated donors (MUD): a single center study 2000 ·Bone Marrow Transplantation ·AA Fauser, Nadežda Basara, IW Blau, (unknown)	10
12	Recurrent venous thrombosis in a patient with chronic lymphocytic leukemia and acquired protein S deficiency 2000 ·PubMed ·Predrag Miljić, (unknown), D Bošković, Petar Antunović, Nadežda Basara, Z Rolović	4
13	Modulatoryin vitroeffects of interleukin-1 receptor antagonist (IL-1Ra) or antisense oligonucleotide to interleukin-1β converting enzyme (ICE) on acute myeloid leukaemia (AML) cell growth 1999 ·Clinical & Laboratory Haematology ·Stanislava Stošić‐Grujičić, Nadežda Basara, Charles A. Dinarello	7
14	Chronic Eosinophilic Leukemia: Successful Treatment with an Unrelated Bone Marrow Transplantation 1998 ·Leukemia & lymphoma ·Nadežda Basara, (unknown), (unknown), Igor‐Wolfgang Blau, Michael Kiehl, M. Bischoff, D Kirsten, A. A. Fauser	21
15	Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients 1998 ·Bone Marrow Transplantation ·Nadežda Basara, (unknown), Eric J. Romer, (unknown), M. Bischoff, D Kirsten, (unknown), S Günzelmann, A. A. Fauser	81
16	Megakaryocyte progenitors in paroxysmal nocturnal haemoglobinuria are sensitive to complement 1996 ·European Journal Of Haematology ·Nadežda Basara, Petar Antunović, (unknown), (unknown), Mirjana Gotić	1
17	The determination of spontaneous megakaryocyte colony formation is an unequivocal test for discrimination between essential thrombocythaemia and reactive thrombocytosis 1995 ·British Journal of Haematology ·Z Rolović, Nadežda Basara, Mirjana Gotić, (unknown), Andrija Bogdanović	33
18	Modulation of Acute Myeloblastic Leukemia (AML) Cell Proliferation and Blast Colony Formation by Antisense Oligomer for IL-1 Beta Converting Enzyme (ICE) and IL-1 Receptor Antagonist (IL-1ra) 1995 ·Journal of Chemotherapy ·Stanislava Stošić‐Grujičić, Nadežda Basara, P Milenković, Charles A. Dinarello	17
19	Decreased Plasma Proteins, Increased Total Plasma-Free Amino Acids, and Disturbed Amino Acid Metabolism in the Hereditary Severe Anemia of the Belgrade Laboratory (b/b) Rat 1993 ·Experimental Biology and Medicine ·(unknown), Z Rolović, Nadežda Basara, Misho O. Simovic, (unknown)	10
20	Abnormal megakaryocytopoiesis in the Belgrade laboratory rat 1991 ·Blood ·Z Rolović, Nadežda Basara, N Stojanović, Nada Suvajdžić, (unknown)	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact